after took covid vaccine was internally cold; after took covid vaccine had arm soreness; after took covid vaccine had headache; redness from anal area; discharge from vaginal area; redness from vaginal area; discharge from anal area; swelling from anal area; swelling from vaginal area; pain from anal area; pain from vaginal area; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (after took covid vaccine was internally cold), PAIN IN EXTREMITY (after took covid vaccine had arm soreness), HEADACHE (after took covid vaccine had headache), ANAL ERYTHEMA (redness from anal area) and VAGINAL DISCHARGE (discharge from vaginal area) in an elderly female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form and ADALIMUMAB (HUMIRA) (unknown route) Solution for injection in pre-filled pen. On an unknown date, the patient experienced FEELING COLD (after took covid vaccine was internally cold), PAIN IN EXTREMITY (after took covid vaccine had arm soreness), HEADACHE (after took covid vaccine had headache), ANAL ERYTHEMA (redness from anal area), VAGINAL DISCHARGE (discharge from vaginal area), VULVOVAGINAL ERYTHEMA (redness from vaginal area), RECTAL DISCHARGE (discharge from anal area), ANORECTAL SWELLING (swelling from anal area), VULVOVAGINAL SWELLING (swelling from vaginal area), PROCTALGIA (pain from anal area) and VULVOVAGINAL PAIN (pain from vaginal area). The patient was treated with CLOBETASOL at an unspecified dose and frequency. At the time of the report, FEELING COLD (after took covid vaccine was internally cold), PAIN IN EXTREMITY (after took covid vaccine had arm soreness) and HEADACHE (after took covid vaccine had headache) had resolved and ANAL ERYTHEMA (redness from anal area), VAGINAL DISCHARGE (discharge from vaginal area), VULVOVAGINAL ERYTHEMA (redness from vaginal area), RECTAL DISCHARGE (discharge from anal area), ANORECTAL SWELLING (swelling from anal area), VULVOVAGINAL SWELLING (swelling from vaginal area), PROCTALGIA (pain from anal area) and VULVOVAGINAL PAIN (pain from vaginal area) had not resolved.        The action taken with mRNA-1273 (Spikevax) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Action taken was reported as unknown for the co-suspect ADALIMUMAB (HUMIRA) with respect to all the events.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial.  Treatment information was not provided.  The reporter's causality for the events of redness from anal area, discharge from vaginal area, redness from vaginal area, discharge from anal area, swelling from anal area, swelling from vaginal area, pain from anal area and pain from vaginal area with HUMIRA(ADALIMUMAB) was a reasonable possibility. The reporter's causality for the events of after took covid vaccine was internally cold, after took covid vaccine had arm soreness and after took covid vaccine had headache with HUMIRA(ADALIMUMAB) was no reasonable possibility.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.   Reporter did not allow further contact